Snapshot from Jul 05, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

United States — Center for Drug Evaluation and Research

Tracked across 1 events · 7 articles · First seen Jun 12, 2026 · Last active Jun 18, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 0
Business
Impact: The United States — Center for Drug Evaluation and Research provided positive pre-submission regulatory feedback for NCX 470, which is crucial for the drug's approval process in China.
Jun 18, 2026 · 7 articles
NEWSDESK
Track United States — Center for Drug Evaluation and Research live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.